Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (61-70 of 217) with videos related to

Pageof 22
Sort By:
Cancer Research|November 17, 2007
Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascadeJuinn-Lin Liu, Zhenyu Mao, Tiffany A LaFortune, et al.
Neuro-Oncology|July 17, 2013
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2Brian M Alexander, Patrick Y Wen, Lorenzo Trippa, et al.
Cancer Immunology Research|April 26, 2014
Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancersJun Yao, Otavia L Caballero, W K Alfred Yung, et al.
Neuro-Oncology|March 25, 2011
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBMYong-Wan Kim, Ta Jen Liu, Dimpy Koul, et al.
Oncotarget|September 15, 2017
APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell deathYu Wang, Shaofang Wu, Siyuan Zheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Kenneth R Hess, et al.
Oncogene|April 12, 2002
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityDimpy Koul, Samar A Jasser, Yiling Lu, et al.
Brain Pathology (Zurich, Switzerland)|January 5, 2002
Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsetsGregory N Fuller, Kenneth R Hess, Chang Hun Rhee, et al.
Molecular Cancer Therapeutics|August 13, 2009
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomasTa-Jen Liu, Dimpy Koul, Tiffany LaFortune, et al.
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivoTa-Jen Liu, Tiffany LaFortune, Toshiyuki Honda, et al.
Pageof 22

Showing results (61-70 of 217) with videos related to

Sort By:
Pageof 22
Cancer Research|November 17, 2007
Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascadeJuinn-Lin Liu, Zhenyu Mao, Tiffany A LaFortune, et al.
Neuro-Oncology|July 17, 2013
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2Brian M Alexander, Patrick Y Wen, Lorenzo Trippa, et al.
Cancer Immunology Research|April 26, 2014
Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancersJun Yao, Otavia L Caballero, W K Alfred Yung, et al.
Neuro-Oncology|March 25, 2011
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBMYong-Wan Kim, Ta Jen Liu, Dimpy Koul, et al.
Oncotarget|September 15, 2017
APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell deathYu Wang, Shaofang Wu, Siyuan Zheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Kenneth R Hess, et al.
Oncogene|April 12, 2002
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activityDimpy Koul, Samar A Jasser, Yiling Lu, et al.
Brain Pathology (Zurich, Switzerland)|January 5, 2002
Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsetsGregory N Fuller, Kenneth R Hess, Chang Hun Rhee, et al.
Molecular Cancer Therapeutics|August 13, 2009
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomasTa-Jen Liu, Dimpy Koul, Tiffany LaFortune, et al.
Molecular Cancer Therapeutics|April 14, 2007
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivoTa-Jen Liu, Tiffany LaFortune, Toshiyuki Honda, et al.
Pageof 22